According to a new study led by Yale Cancer Center and Department of Neurology researchers, a simple blood draw may be the first step in helping to discover tumor reactive immune or T cells to treat advanced melanoma, a deadly form of skin cancer.
from News Medical Medical Research News Feed https://ift.tt/3uR78SO
0 Comments